Proteomics for the investigation of acute kidney injury

Contributions to Nephrology

Volumn 160, Issue , 2008, Pages 1-16

  Devarajan, P ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ANIMAL; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PROTEOMICS; REVIEW;

ANIMALS; HUMANS; KIDNEY FAILURE, ACUTE; PROTEOMICS;

EID: 48949104744     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000125893     Document Type: Review

References (102)

1. Lameire N, Van Biesen W, Vanholder R: Acute renal failure. Lancet 2005;365:417-430.
2. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004;114:5-14.
3. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C: for the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-818
4. Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006;17:1503-1520.
5. Devarajan P: Emerging biomarkers of acute kidney injury. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 203-212.
6. Hewitt SM, Dear J, Star RA: Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 2004;15:1677-1689.
7. Herget-Rosenthal S, Marggraf G, Hüsing J, Goring F, Pietruck F, Janssen O, Phillip T, Kribben A: Early detection of acute renal failure by serum cystatin C. Kidney Int 2004;66:1115-1122.
8. Bellomo R, Kellum JA, Ronco C: Defining acute renal failure: physiological principles. Intensive Care Med 2004;30:33-37.
9. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH: Anaritide in acute tubule necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997;336:828-834.
10. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O'Shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W, Pike M, Guler H-P: Multicenter clinical trial of recombinant human insulin-like growth factor-1 in patients with acute renal failure. Kidney Int 1999;55:2423-2432.
11. American Society of Nephrology Renal Research Report: J Am Soc Nephrol 2005;16:1886-1893.
12. Devarajan P, Mishra J, Supavekin S, Patterson LT, Potter SS: Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab 2003;80:365-376.
13. Han WK, Bonventre JV: Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 2004;10:476-482.
14. Zhou H, Hewitt SM, Yuen PST, Star RA: Acute kidney injury biomarkers - needs, present status, and future promise. Nephrology Self Assessment Program, American Society of Nephrology. NephSAP 2006;5:63-71.
15. Perco P, Pleban C, Kainz A, Lukas A, Mayer G, Mayer B, Oberbauer R: Protein biomarkers associated with acute renal failure and chronic kidney disease. Eur J Clin Invest 2006;36:753-763.
16. Thongboonkerd V: Proteomics in nephrology: current status and future directions. Am J Nephrol 2004;24:360-378.
17. Thongboonkerd V: Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery. Expert Rev Proteomics 2005;2:349-366.
18. Vidal BC, Bonventre JV, Hsu SI-H: Towards the application of proteomics in renal disease diagnosis. Clin Sci 2005;109:421-430.
19. Pisitkun T, Johnstone R, Knepper MA: Discovery of urinary biomarkers. Mol Cell Proteomics 2006;5:1760-1771.
20. O'Riordan E, Gross SS, Goligorsky MS: Technology insight: renal proteomics - at the crossroads between promise and problems. Nat Clin Pract Nephrol 2006;2:445-458.
21. Witzmann FA, Li J: Proteomics and nephrotoxicity. Contrib Nephrol. Basel, Karger, 2004, vol 141, pp 104-123.
22. Gibbs A: Comparison of the specificity and sensitivity of traditional methods for assessment of nephrotoxicity in the rat with metabolomic and proteomic methodologies. J Appl Toxicol 2005;25:277-295.
23. Betton GR, Kenne K, Somers R, Marr A: Protein biomarkers of nephrotoxicity; a review and findings with cyclosporine A, a signal transduction kinase inhibitor and N-phenylanthranilic acid. Cancer Biomark 2005;1:59-67.
24. Safirstein RL: Acute renal failure: from renal physiology to the renal transcriptome. Kidney Int 2004;66:S62-S66.
25. Scaub S, Wilkins JA, Rush D, Nickerson P: Developing a tool for noninvasive monitoring of renal allografts. Expert Rev Proteomics 2006;3:497-509.
26. Wishart DS: Metabolomics in monitoring kidney transplants. Curr Opin Nephrol Hypertens 2006;15:637-642.
27. Thongboonkerd V, Klein JB, Jevans AW, McLeish KR: Urinary proteomics and biomarker discovery for glomerular diseases. Contrib Nephrol. Basel, Karger, 2004, vol 141, pp 292-307.
28. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P: Differential gene expression following early renal ischemia-reperfusion. Kidney Int 2003;63:1714-1724.
29. Cheng C-W, Rifai A, Ka S-M, Shui H-A, Lin Y-F, Lee W-H, Chen A: Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure. Kidney Int 2005;68:2694-2703.
30. Thakar CV, Zahedi K, Revelo MP, Wang Z, Burnham CE, Barone S, Bevans S, Lentsch AB, Rabb H, Soleimani M: Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest 2005;115:3451-3459.
31. Yuen PST, Jo S-K, Holly MK, Hu X, Star RA: Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses. Physiol Genomics 2006;25:375-386.
32. Ichimura T, Bonventre JC, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M: Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998;273:4135-4142.
33. Muramatsu Y, Tsujie M, Kohda Y, Pham B, Perantoni AO, Zhao H, Jo S-K, Yuen PST, Craig L, Hu X, Star RA: Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int 2002;62:1601-1610.
34. Zahedi K, Wang Z, Barone S, Prada AE, Kelly CN, Casero RA, Yokota N, Porter CW, Rabb H, Soleimani M: Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol 2003;284:F1046-F1055.
35. Saikumar P, Venkatachalam MA: Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 2003;6:512-521.
36. Kaushal GP, Basnakian AG, Shah SV: Apoptotic pathways in ischemic acute renal failure. Kidney Int 2004;66:500-505.
37. Dagher PC: Apoptosis in ischemic renal injury: roles of GTP depletion and p53. Kidney Int 2004;66:506-509.
38. Del Rio M, Imam A, DeLeon M, G, Mishra J, Ma Q, Parikh S, Devarajan P: The death domain of kidney ankyrin interacts with Fas and promotes Fas-mediated cell death in renal epithelia. J Am Soc Nephrol 2004;15:41-51.
39. Burns AT, Davies DR, McLaren AJ, Cerundolo L, Morris PJ, Fuggle SV: Apoptosis in ischemia/reperfusion injury of human renal allografts. Transplantation 1998;66:872-876.
40. Oberbauer R, Rohrmoser M, Regele H, Muhlbacher F, Mayer G: Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 1999;10: 2006-2013.
41. Schwarz C, Hauser P, Steininger R, Regele H, Heinze G, Mayer G, Oberbauer R: Failure of Bcl-2 up-regulation in proximal tubular epithelial cells of donor kidney biopsy specimens is associated with apoptosis and delayed graft function. Lab Invest 2002;82:941-948.
42. Hoffman SC, Kampen RL, Amur S, Sharaf MA, Kleiner DE, Hunter K, John Swanson S, Hale DA, Mannon RB, Blair PJ, Kirk AD: Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 2002;74:916-923.
43. Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, Feuerstein D, Kaskel FJ, Tellis V, Devarajan P: Activation of mitochondrial apoptotic pathways in human renal allografts following ischemiare-perfusion. Transplantation 2003;76:50-54.
44. Hauser P, Schwarz C, Mitterbauer C, Regele HM, Muhlbacher F, Mayer G, Perco P, Mayer B, Meyer TW, Oberbauer R: Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest 2004;84:353-361.
45. Ortiz A, Justo P, Sanz A, Lorz C, Egido J: Targeting apoptosis in acute tubular injury. Biochem Pharmacol 2003;66:1589-1594.
46. Fleischer A, Ghadiri A, Dessauge F, Duhamel M, Rebollo MP, Alvarez-Franco F, Rebollo A: Modulating apoptosis as a target for effective therapy. Mol Immunol 2006;43:1065-1079.
47. Faubel S, Edelstein CL: Caspases as drug targets in ischemic organ injury. Curr Drug Targets Immune Endocr Metabol Disord 2005;5:269-287.
48. Green DR, Kroemer G: Pharmacologic manipulation of cell death: clinical applications insight? J Clin Invest 2005;115:2610-2617.
49. Bouchier-Hayes L, Lartigue L, Newmeyer DD: Mitochondria: pharmacological manipulation of cell death. J Clin Invest 2005;115:2640-2647.
50. Letai A: Pharmacologic manipulation of Bcl-2 family members to control cell death. J Clin Invest 2005;115:2648-2655.
51. Lavrik IN, Golks A, Krammer PH: Caspases: pharmacological manipulation of cell death. J Clin Invest 2005;115:2665-2672.
52. Jani A, Ljubanivic D, Faubel SG, Kim J, Mischak R, Edelstein CL: Caspase inhibition prevents the increase in caspase-3, -2, -8 and -9 activity and apoptosis in the cold ischemic mouse kidney. Am J Transplant 2004;8:1246-1254.
53. Hoglen NC, Chen LS, Fisher CD, Hirakawa BP, Groessl T, Contreras PC: Characterization of IDN-6556 (3-[2-(2-tert-butyl-phenylaminooxalyl)-amino]- propionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)-pentanoic acid): a liver-targeted caspase inhibitor. J Pharmacol Exp Ther 2004;309:634-640.
54. Quadri SM, Segall L, de Perrot M, Han B, Edwards V, Jones N, Waddell TK, Liu M, Keshavjee S: Caspase inhibition improves ischemia-reperfusion injury after lung transplantation. Am J Transplant 2005;5:292-299.
55. Mishra J, Ma Q, Prada A, Zahedi K, Yang Y, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel urinary biomarker for ischemic injury. J Am Soc Nephrol 2003;4:2534-2543.
56. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL): a novel urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004;24:307-315.
57. Mori K, Lee HT, Rapoport D, Drexler I, Foster K, Yang J, Schmidt-Ott, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005;115:610-621.
58. Schmitt-Ott KM, Mori K, Kalandadze A, Li J-Y, Paragas N, Nicholas T, Devarajan P, Barasch J: Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2005;15:442-449.
59. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet 2005;365:1231-1238.
60. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT: Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006;105:485-491.
61. Mishra J, Ma Q, Kelly C, Mitsnefes M, Mori K, Barasch J, Devarajan P: Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006;21:856-863.
62. Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J, Edelstein CL, Devarajan P: Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006;6:1639-1645.
63. Han WK, Bailly V, Abichandani R, Thadani R, Bonventre JV: Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002;62:237-244.
64. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV: Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004;286:F552-F563.
65. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV: Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006;290:F517-F529.
66. Mitsnefes M, Kathman T, Mishra J, Kartal J, Khoury P, Nickolas T, Barasch J, Devarajan P: Serum NGAL as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007;22:101-108.
67. Wang Z, Zahedi K, Barone S, Tehrani K, Rabb H, Matlin K, Casero RA, Soleimani M: Overexpression of SSAT in kidney cells recapitulates various phenotypic aspects of kidney ischemia-reperfusion injury. J Am Soc Nephrol 2004;15:1844-1852.
68. Tarabishi R, Zahedi K, Mishra J, Ma Q, Kelly C, Tehrani K, Devarajan P: Induction of Zf9 in the kidney following early ischemia/reperfusion. Kidney Int 2005;68:1511-1519.
69. Hochegger K, Koppelstatter C, Tagwerker A, Huber JM, Heininger D, Mayer G, Rosenkranz AR: p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia reperfusion injury. Am J Physiol Renal Physiol 2007; in press.
70. Nath KA, Dvergsten J, Correa-Rotter R, Hostetter TH, Manivel JC, Rosenberg ME: Induction of clusterin and chronic oxidative renal disease in the rat and its dissociation from cell injury. Lab Invest 1994;71:209-218.
71. Caron A, Desrosiers RR, Beliveau R: Kidney ischemia-reperfusion regulates expression and distribution of tubulin subunits, β-actin and rho GTPases in proximal tubules. Arch Biochem Biophys 2004;431:31-46.
72. Akagi R, Takahashi T, Sassa S: Cytoprotective effects of heme oxygenase in acute renal failure. Contrib Nephrol. Basel, Karger, 2005, vol 148, pp 70-85.
73. Takahashi T, Itano Y, Noji S, Matsumotot K, Taga N, Mizukawa S, Toda N, Matsumi M, Morita K, Hirakawa M: Induction of renal metallothionein in rats with ischemic renal failure. Res Commun Mol Pathol Pharmacol 2001;110:147-160.
74. Nishiyama J, Kobayashi S, Ishida A, Nakabayashi I, Tajima O, Miura S, Katayama M, Nogami H: Up-regulation of galectin-3 in acute renal failure of the rat. Am J Pathol 2000;157:815-823.
75. Bonventre JV, Sukhatme VP, Bamberger M, Ouellette AJ, Brown D: Localization of the protein product of the immediate early growth response gene, Egr-1, in the kidney after ischemia and reperfusion. Cell Regul 1991;2:251-260.
76. Briscoe DM, Pober JS, Harmon WE, Cotran RS: Expression of vascular cell adhesion molecule-1 in human renal allografts. J Am Soc Nephrol 1992;3:1180-1185.
77. Witzgall R, Brown D, Schwarz C, Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogeneous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994;93:2175-2188.
78. Aufricht C: Heat-shock protein 70: molecular supertool? Pediatr Nephrol 2005;20:707-713.
79. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L, Jeyarajah DR, Zhou XJ, Zhou H, Chiquett B, Nagami GT, Lu CY: Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 2005;16:3315-3325.
80. Gobe G, Zhang ZJ, Wollgoss DA, Schoch E, Hogg NA, Endre ZH: Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 2000;11:454-467.
81. Yoshino J, Monkawa T, Tsuji M, Hayashi M, Saruta T: Leukemia inhibitory factor is involved in tubular regeneration after experimental acute renal failure. J Am Soc Nephrol 2003;14:3090-3101.
82. + exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis 2003;42:497-506.
83. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Burst-Singer K, Nast C, Cohen AH, Ormos J, Silva FG: Human acute tubular necrosis: a lectin and immunohistochemical study. Hum Pathol 1995;26:230-239.
84. Devarajan P: Proteomics for biomarker discovery in acute kidney injury. Semin Nephrol 2007;27:637-651.
85. Schaub S, Rush D, Wilkins J, Gibson IW, Weiler T, Sangster K, Nicolle L, Kappinski M, Jeffery J, Nickerson P: Proteome-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 2004;15:219-227.
86. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P: Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 2004;65:323-332.
87. Nguyen MT, Ross GF, Dent CL, Devarajan P: Early prediction of acute renal injury using urinary proteomics. Am J Nephrol 2005;25:318-326.
88. Lefler DM, Pafford RG, Black NA, Raymond JR, Arthur JM: Identification of proteins in slow continuous ultrafiltrate by reversed-phase chromatography and proteomics. J Proteome Res 2004;3:1254-1260.
89. Zhou H, Pisitkun T, Aponte A, Yuen PST, Hoffert JD, Yasuda H, Hu X, Chawla L, Shen R-F, Knepper MA, Star RA: Exosomal fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int 2006;70:1847-1857.
90. Pisitkun T, Shen RF, Knepper MA: Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004;101:13368-13373.
91. Zhou H, Yuen PS, Pisitkun T, Gonzales PA, Yasuda H, Dear JW, Gross P, Knepper MA, Star RA: Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int 2006;69:1471-1476.
92. Molls RM, Savransky V, Liu M, Bevans S, Mehta T, Tuder RM, King LS, Rabb H: Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol Renal Physiol 2006;290:F1187-F1193.
93. Holly MK, Dear JW, Hu X, Schechter AN, Gladwin MT, Hewitt SM, Yuen PST, Star RA: Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int 2006;70:496-506.
94. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004;351:159-169.
95. Melnikov VY, Ecder T, Fantuzzi G, Siegmund B, Lucia MS, Dinarello CA, Schrier RW, Edelstein CL: Impaired IL-18 processing protects caspase-1 deficient mice from ischemic acute renal failure. J Clin Invest 2001;107:1145-1152.
96. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL: Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004;43:405-414.
97. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL: Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005;16:3046-3052.
98. Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, Dent C, Devarajan P, Edelstein CL: Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006;70:199-203.
99. Herget-Rosenthal S, Poppen D, Husing J, Marggraf G, Pietruck F, Jakob H-G, Philipp T, Kribben A: Prognostic value of tubular proteinuria and enzymuria in non-oliguric acute tubular necrosis. Clin Chem 2004;50:552-558.
100. VandeVoorde RG, Katlman TI, Ma Q, Kelly C, Mishra J, Dent CA, Mitsnefes MM, Devarajan P: Serum NGAL and cystatin C as predictive biomarkers for acute kidney injury. J Am Soc Nephrol 2006;17:404.
101. Dent CL, Ma Q, Dastrala S, Bennett M, Mitsnefes MM, Barasch J, Devarajan P: Plasma NGAL predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007;11:R127.
102. Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, Syed H, Ali S, Barasch J, Devarajan P: Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008, in press.